Clinical Trial Update: A Study of AGEN2034 in Advanced Tumors and Cervical Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of AGEN2034 in advanced tumors and cervical cancer has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cervical Cancer

Drugs mentioned

• AGEN2034

Snippet

Sponsor: Agenus Inc. | Conditions: Advanced Cancer, Cervical Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-07-30